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In March 2011, the German sentinel surveillance sys-
tem for influenza (Arbeitsgemeinschaft Influenza 
(AGI)) was complemented by an Internet-based syndro-
mic monitoring system (GrippeWeb) for acute respira-
tory infections (ARI) and influenza-like-illness (ILI). To 
assess representativeness of GrippeWeb participants, 
key demographic variables and lifetime prevalence 
of asthma and diabetes were compared with data 
from the general population of Germany. To ‘validate’ 
GrippeWeb, we compared weekly ARI and medically 
attended ARI (MAARI) rates, generated between weeks 
35/2011 and 34/2012, with AGI MAARI rates and over-
laid GrippeWeb ILI rates with the number of positive 
influenza samples obtained by the AGI. GrippeWeb 
had high weekly participation rates (62% of partici-
pants reported in ≥90% of possible weeks). Although 
it varied by age group, participants reported a mean 
of between 1.3 and 6.0 ARI episodes and between 0.1 
and 2.4 ILI episodes during the study year. Estimated 
GrippeWeb MAARI incidence was very similar to the 
AGI MAARI incidence and influenza circulation was 
reflected well in the GrippeWeb ILI rates. GrippeWeb 
became a reliable monitoring system shortly after 
implementation, capturing the burden of ARI and ILI 
at general population level. The high degree of agree-
ment between GrippeWeb’s and AGI’s MAARI data 
lends support to the validity of both systems.
Introduction
In Europe, surveillance for influenza is traditionally 
based on sentinel systems of primary care physicians 
who collect syndromic data on patients presenting with 
influenza-like illness (ILI) or acute respiratory infection 
(ARI) [1]. To this end, the Working Group for Influenza 
(Arbeitsgemeinschaft Influenza (AGI)) in Germany was 
founded in 1992 [2]. It is the German member of the 
European influenza surveillance network (EISN) coordi-
nated by the European Centre for Disease Prevention 
and Control (ECDC) and the respective system of the 
World Health Organization Regional Office for Europe 
(EuroFlu) [3]. While most sentinel systems in Europe 
collect ILI data, the AGI collects ARI data. Because this 
type of surveillance focuses on illnesses of patients 
who seek healthcare, several countries have added 
Internet-based monitoring systems, in which data are 
collected from the population directly [4-10]. In March 
2011, the Robert Koch Institute (RKI) launched an 
Internet-based syndromic monitoring system for ARI 
and ILI in Germany, named GrippeWeb [11]. Experiences 
from similar projects in other countries have shown 
that continuous participation of registered individuals 
is essential for data quality [4,5,7,10,12], but some sys-
tems have reported difficulties in achieving sustained 
participation [9,13]. Compared with the levels of ILI 
in the sentinel systems, the rise, peak and fall of ILI 
activity in the Internet-based and sentinel systems of 
Belgium, the Netherlands and Portugal, respectively, 
occurred at similar times [7-10]. However, a direct, 
quantitative comparison of medically attended illness 
rates of the two systems has not been published. 
Representativeness of the Internet-based systems 
has been reported to be good in terms of age and co-
morbidity [7,8], but there were difficulties in reaching 
minors as well as elderly people [7-10].
GrippeWeb [14] runs throughout the year. Every per-
son residing in Germany who is at least 14 years-old 
can register. Parents need to register separately, 
but one parent can report for their children aged 13 
years or younger. Upon registration, participants 
answer 10 questions on demographic variables, life-
time physician-diagnosed chronic conditions, smok-
ing, household size, daily occupation and main mode 
of transportation. Since the launch of the system in 
March 2011, participants have been recruited through 
paper-based or online media reports, during public 
events where GrippeWeb was presented and by word 
of mouth. In addition, public institutions, such as 
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county health departments, were provided with leaf-
lets for further distribution to popularise GrippeWeb. 
GrippeWeb is carried out according to the German leg-
islation on data protection. The GrippeWeb procedures 
were approved by the German Federal Commissioner 
for Data Protection and Freedom of Information. 
Every Monday morning, participants receive an email 
summarising the GrippeWeb results published on the 
system’s website and inviting them to complete their 
weekly questionnaire. In this questionnaire, partici-
pants are asked whether they have experienced the 
onset of a new respiratory illness during the previous 
week (Monday to Sunday). If the participant has had no 
respiratory illness with new symptom onset, no further 
questions need to be answered. In the alternative case, 
participants are asked to report date of onset, select 
symptoms from a short list (cough, sore throat, fever, 
runny nose), if they have consulted a physician because 
of the illness and whether they have been able to con-
tinue their usual daily occupation. Influenza vaccina-
tion is recorded weekly during the winter season as a 
separate item on the questionnaire. If a participant has 
missed filling in the questionnaire of a particular week, 
they can report weekly answers up to the previous four 
weeks. GrippeWeb defines an ARI as a subjectively 
reported respiratory illness with new onset of fever 
(subjective) or cough or sore throat. ILI is defined as 
a subjectively reported respiratory illness with a new 
onset of fever and cough or sore throat.
Individual results are fed back to each participant in 
a diary function; aggregated results are published in 
weekly reports on the website. To motivate partici-
pants aged 18 years or older to report as regularly as 
possible, they have the option to take part in a prize 
draw where a number of technical devices, such as a 
notebook or digital camera, can be won. The chance of 
winning can be increased by accumulating points with 
every report during a one-year period between August 
and July, after which winners are identified. Staff and 
family of the authoring institute (RKI) are excluded 
from participating in the draw.
Here we describe the characteristics of GrippeWeb and 
analyse the representativeness of its participants com-
pared with the general population of Germany. We pre-
sent ARI and ILI data from the first year of GrippeWeb, 
including the influenza season 2011/12, and compare 
these data with those generated by the AGI. 
Methods
We analysed GrippeWeb data collected from week 
35/2011 to week 34/2012 (52 weeks). To calculate the 
proportion of weekly reports submitted after registra-
tion, we divided the participants in two groups: (i) those 
already registered at week 35/2011 (the beginning of 
the analysed period); and (ii) those who registered 
after the period of observation had started (for exam-
ple, in week 40/2011). To determine the denominator 
of the maximum number of possible reports between 
weeks 35/2011 and 34/2012 (the end of the period of 
analysis), we used as the denominator the total num-
ber of weeks between week 35/2011 and 34/2012 (first 
group) or the number of weeks from the beginning of 
registration until week 34/2012 (second group). For the 
numerator, we calculated for both groups the number 
of weekly reports submitted. 
Representativeness
We calculated the proportional age distribution of 
GrippeWeb participants as of week 34/2012 for six 
age groups (0–4, 5–14, 15–24, 25–34, 35–59 and >59 
years), in alignment with the AGI age groups, the distri-
bution by sex and the geographical distribution by fed-
eral state and compared these with the population of 
Germany as of 31 December 2011 using data provided 
by the German Federal Statistical Office (Destatis) [14]. 
In addition, we compared the age-adjusted lifetime 
prevalence of asthma and diabetes among GrippeWeb 
participants aged 18 years or above with those 
obtained in a representative survey of the population 
of Germany in 2010 (GEDA) [15,16]. 
Impact of the prize draw
We investigated whether participants enrolled in 
the prize draw differed from those not enrolled and 
whether participation in the draw skewed responses. 
We compared the age and sex distribution, response 
rates and ARI/ILI rates in the two groups. Because the 
minimum age to take part in the prize draw was 18 
years, we restricted these comparisons for participants 
aged at least 18 years.
Calculation of ARI and ILI estimates
Weekly ARI/ILI rates were calculated by dividing the 
number of participants with ARI/ILI in a particular 
week by the total number of reporting participants in 
the same week. To calculate the mean number of ARI 
(ILI) during the one year study period, we used only the 
cohort of participants that were registered already on 
week 35/2011 and submitted a report in more than 46 
(90%) of the 52 weeks in the following year. To estimate 
ARI/ILI rates for the general population of Germany, 
the sample was weighted according to the sex and age 
distribution based on the 2011 data of DESTATIS, the 
Federal Statistical Office [14]. We assigned each indi-
vidual a weight according to the following formula [9]:
Wi = Pi Germany / Pi GrippeWeb
Wi = weight of individual GrippeWeb participant
Pi Germany = proportion of the general population of 
Germany in the same age and sex group as the indi-
vidual i
Pi GrippeWeb = proportion of the GrippeWeb population in 
the same age and sex group as the individual i;
To reduce the effect of individuals who register as a 
response to an acute illness and because participants 
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can report up to four weeks backwards, we restricted 
our dataset to participants’ fifth and subsequent 
reports to calculate weekly ARI/ILI rates. Recurrent epi-
sodes of ARI and ILI of a participant were only counted 
if they did not report an ARI or ILI for at least one week 
after the last ARI/ILI.
Comparison between ARI/ILI rates in 
GrippeWeb and the sentinel system of the AGI
The AGI defines ARI as a physician-diagnosed acute 
pharyngitis or bronchitis or pneumonia with or without 
fever [2]. To estimate the activity of medically attended 
ARI (MAARI), the AGI calculates the incidence of ARI 
in persons who consulted a physician because of it 
Figure 1
GrippeWeb participants (week 34/2011) and the general population of Germany (as of 31 December 2011) by federal state 
(A) and age group (B), Germany
a Data from DESTATIS (Federal Statistical Office).
A Participation by federal state
B Participation by age group
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(MAARI incidence) [17]. The AGI complements syndro-
mic surveillance with virological data from samples 
taken by a subgroup of all sentinel physicians [18]. 
We conducted two ‘validation’ procedures of 
GrippeWeb data using AGI data. Firstly, to compare 
MAARI incidence of the AGI (AGI MAARI incidence) 
with data obtained by GrippeWeb (GrippeWeb MAARI 
incidence), we multiplied the weekly ARI rate with the 
weekly proportion of ARI patients who had indicated 
that they had consulted a physician due to their illness. 
Secondly, to investigate if the  influenza wave of the 
2011/12 season was reflected in GrippeWeb data, we 
overlaid ILI rates obtained by GrippeWeb (because ILI 
is more specific for influenza than ARI) with the num-
ber of samples positive for influenza A(H3N2) and B, 
the two circulating virus (sub)types in Germany during 
the 2011/12 season. 
Statistical analyses
Data analyses were performed using Stata version 12 
(Stata Corporation, United States). For comparisons of 
two proportions, we used a chi-squared test, for com-
parisons of numerical values between two groups, we 
used the Mann–Whitney U test or Student’s t-test. To 
compare the values of the GrippeWeb MAARI incidence 
and the GrippeWeb ARI incidence, respectively, with 
the AGI MAARI incidence and to compare ARI/ILI rates 
in GrippeWeb participants enrolled and not enrolled in 
the prize draw, we calculated the Pearson correlation 
coefficient r or Spearman’s rho. To measure similarity 
of pairs of time series as a function of time lag, we cal-
culated cross-correlations. All p values were calculated 
using two-sided tests. P values of less than 0.05 were 
considered statistically significant. Weekly GrippeWeb 
ARI/ILI incidences were calculated as a three-week 
moving average.
Results
The number of registered participants rose from 1,385 
in week 35/2011 to 3,803 in week 34/2012. The total 
cohort of participants who were registered at any time 
between week 35/2011 and week 34/2012 consisted of 
4,102 participants. During the study period, 3,933 par-
ticipants (96%) contributed reports. The major source 
that led participants to find out about GrippeWeb 
was the Internet (56%, 1,616 of 2,902 who answered 
the question). During the period analysed, partici-
pants contributed 125,393 reports to our dataset. For 
the analysis of ARI and ILI rates, 113,919 and 115,016 
reports respectively were included, after exclusion of 
the first four reports submitted by participants and 
after exclusion of recurrent ARI and ILI episodes from 
one week to another. 
During the period analysed, more than half of the par-
ticipants (2,144/4,102) reported to GrippeWeb in more 
than 96% of the possible weeks, 62% (2,553/4,102) in 
at least 90% and 68% (2,805/4,102) of participants 
reported in at least 80%.
Representativeness
Participants from all 16 German federal states regis-
tered for GrippeWeb. While the number of GrippeWeb 
participants by state correlated well overall with the 
number of residents of the respective state (rho = 0.90, 
p<0.001), there were differences between individual 
states. GrippeWeb participants were over-represented 
in several states (n=4, particularly the federal state 
of Berlin), and under-represented in Bavaria, Baden-
Württemberg, Lower Saxony, North Rhine-Westphalia, 
Saxony and Thuringia (Figure 1A).
The age-adjusted proportion of female GrippeWeb par-
ticipants was higher than in the general population of 
Germany (52%  vs 51% , chi-squared test: p<0.001). 
All age groups were represented in GrippeWeb. 
People aged 35–59 years constituted the largest por-
tion in both GrippeWeb and the general population 
of Germany (Figure 1B). The proportion of 0–4, 5–14 
and 35-59 year-old GrippeWeb participants was sig-
nificantly higher, whereas the proportion of 15–24 and 
>59 year-old participants was significantly lower com-
pared with the proportions in the general population 
of Germany. 
The lifetime prevalence of asthma in GrippeWeb par-
ticipants aged 18 and older was lower than the lifetime 
prevalence in the adult population of Germany (8.1% 
vs 9.7%, chi-squared test: p<0.001). GrippeWeb par-
ticipants had also a lower lifetime prevalence of dia-
betes compared with that of the general population of 
Germany (5.3% vs 8.8%, chi-squared test: p<0.001). 
Impact of the prize draw
Among participants aged 18 and older, 80% (n=2,411) 
of 3,018 participants had signed up for the prize draw. 
Compared with GrippeWeb participants who had 
not enrolled in the draw, those who had enrolled did 
not differ by age (mean age 44.1 years vs 44.1 years, 
Mann–Whitney U test: p=0.70) and sex (chi-squared 
test: p=0.60). Weekly ARI and ILI rates were similar in 
both groups (for ARI, r= 0.90, p<0.001, 95% confidence 
interval (CI): 0.83–0.94 and for ILI, r= 0.42, p<0.002, 
95% CI: 0.17–0.62) (Figure 2A). 
Regarding the reporting rate, those enrolled in the 
draw reported more consistently throughout the 
study period. For example, 67% (1,607/2,411) of those 
enrolled vs 55% (332/607) of those not enrolled sub-
mitted at least 90% of the possible number of reports 
(Figure 2B; Mann–Whitney U test: p <0.001).
Estimates of ARI and ILI among 
GrippeWeb participants
During the observed time period, estimated weekly ARI 
rates ranged between 3.0% (95% CI: 2.3–3.7) and 8.4% 
(95% CI: 6.7–10.1) for all ages, between 4.9% (95% CI: 
3.2–6.7) and 14.1% (95% CI: 10.8–17.5) for children 
(aged 14 years or younger) and between 2.7% (95% CI: 
1.9–3.5) and 8.2% (95% CI: 6.4–10.2) for participants 
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Figure 2
GrippeWeb participants enrolled and not enrolled in the prize draw: proportion of possible weekly reports after registration 
(A) and three-week moving average of reported acute respiratory illness and influenza-like illness (B), Germany, weeks 
35/2011–34/2012
ARI: acute respiratory illness; ILI: influenza-like illness.
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Figure 3
Three-week moving average for children ≤14 years, participants >14 years and all age groups measured by GrippeWeb for 
acute respiratory illness (A) and influenza-like illness (B), Germany, weeks 35/2011–34/2012
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aged >14 years (Figure 3A). ILI rates ranged between 
0.5% (95% CI: 0.2–0.8) and 1.8% (95% CI: 1.3–2.3) 
for all ages, between 1.1% (95% CI: 0.3–2.0) and 5.8% 
(95% CI: 3.9–7.7) for children ≤14 years and between 
0.4% (95% CI: 0.1–0.7) and 1.3% (95% CI: 0.7–1.9) for 
participants aged >14 years (Figure 3B). Rates of ARI 
and ILI reports dropped around weeks 40–42/2011, 
01/2012 and 14/2012, particularly in children aged 
0–14 years, coinciding with the autumn, Christmas 
and Easter holiday periods. ILI rates peaked in weeks 
7–9/2012 in participants aged >14 years and in week 
11/2012 in children aged ≤14 years.  In an average 
week, GrippeWeb received 46 ARI and 15 ILI reports 
among children (aged 0–14 years) and 88 ARI and 16 
ILI reports of participants aged >14 years. Mean weekly 
ARI rates in children were between 1.0 and 2.7 times 
higher than those in participants aged >14 years, while 
the mean weekly ILI rates in children were between 2.0 
and 5.4 times higher. 
During the period analysed, the mean number of ARI 
and ILI reports was strongly age dependent, varying 
from 6.0 in children aged 0–4 years to 1.3 in partici-
pants aged 60 years or older for ARI; for ILI, it varied 
from 2.4 in the 0–4 year-olds to 0.1 in those aged ≥60 
years (Table). 
Overall, participants consulted a physician in 18% and 
42% of reported ARI and ILI episodes, respectively, due 
to their illness. After stratification by age, a physician 
was consulted most frequently for children aged 0–4 
years (for ARI in 25% of episodes and for ILI in 49%) 
and participants aged 15–34 years consulted least fre-
quently for ARI (15%) and adults aged 35–59 years least 
frequently for ILI (39%). 
Regarding school or work absenteeism, participants 
reported in 30% of ARI and in 68% of ILI episodes that 
they refrained from their usual daily activity (day care, 
school, work, etc.) due to their illness.
Comparison of GrippeWeb ARI/
ILI rates with data from the AGI
The weekly GrippeWeb ARI incidence and MAARI inci-
dence curves show the same trends as the AGI’s con-
sultation incidence curve (Figure 4). Peaks of incidence 
curves occurred a little earlier for GrippeWeb ARI 
(week 5/2012) and GrippeWeb MAARI (week 7/2012) 
compared with AGI MAARI (week 9/2012). The weekly 
GrippeWeb ARI incidences were about 4.8–10.8 times 
higher than the AGI MAARI incidence. Over the whole 
period analysed, the weekly GrippeWeb MAARI inci-
dences differed by a factor 0.6–1.4 from the AGI MAARI 
incidences, and by a factor of only 0.9–1.4 (GrippeWeb 
MAARI/AGI MAARI) when considering only weeks 
6–16/2012, which were retrospectively defined by the 
AGI as the time when the influenza epidemic occurred 
in Germany [2] (Figure 4). The GrippeWeb ARI incidence 
and MAARI incidence correlated significantly with the 
AGI MAARI incidence (r = 0.80 p<0.001, 95% CI: 0.68–
0.88 (GrippeWeb ARI) and r = 0.89, p<0.001, 95% CI: 
0.82–0.94 (GrippeWeb MAARI)). The correlation could 
be improved up to 0.89 by using a lag of two weeks 
for the correlation of GrippeWeb ARI incidence and AGI 
MAARI incidence.
Superimposing GrippeWeb ILI rates with the number 
of samples positive for influenza A(H3N2) and influ-
enza B virus identified by the AGI demonstrated that 
the occurrence of the influenza wave was reflected in 
the ILI rates of children, but was less obvious among 
adults (Figure 5). Circulation of influenza A(H3N2) virus 
reached its peak in week 9/2012, preceding that of 
influenza B in week 12. During the period when influ-
enza virus circulated most, ILI rates among adults 
peaked during weeks 7–9/2012, while among children 
they peaked during weeks 9–12/2012. 
Table
Number of acute respiratory illness and influenza-like illness reports of GrippeWeb participants, Germany, during  a one-
year period (weeks 35/2011–34/2012)
Age group in yearsa Number of participantsb
Number of ARI reports Number of ILI reports
Mean Median (25% percentile; 75% percentile) Mean
Median 
(25% percentile; 75% percentile)
≤4 38 6.0 6 (4; 8) 2.4 2 (1; 3)
5–14 115 3.4 3 (2; 4) 0.9 1 (0; 1)
15–34 125 3.2 3 (2; 4) 0.5 0 (0; 1)
35–59 438 2.3 2 (1; 3) 0.4 0 (0; 1)
≥60 64 1.3 1 (0; 2) 0.1 0 (0; 0)
ARI: acute respiratory illness; ILI: influenza-like-illness.
a Participants were included in the calculation only if they were already registered in week 35/2011 and reported to GrippeWeb a minimum 47 
weeks out of the possible 52 weeks during weeks 35/2011 to 34/2012.
b One parent can report for children aged 13 years or younger.  
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Discussion
During the one-year study period, at the start of 
GrippeWeb’s existence, the system experienced a 
constantly growing number of participants, with very 
high weekly reporting rates throughout the year. 
Participants came from all German federal states and 
all age groups were represented. Signing up to the 
prize draw did not seem to affect validity of reporting, 
but enhanced reporting rates. Estimated GrippeWeb 
MAARI incidence was in the same range as the MAARI 
incidence measured by the physician-based AGI sys-
tem and influenza circulation was reflected by the 
GrippeWeb ILI rates, particularly among children. 
Start-up systems running with voluntary participation, 
such as GrippeWeb, always need to reach a minimum 
number of participants to be able to generate reason-
ably precise and reliable data [19]. During the period 
analysed, we were able to almost triple the number of 
GrippeWeb participants. Although statistically signifi-
cant differences of the GrippeWeb participants existed 
when compared to the general population in Germany, 
these may have resulted because of the large num-
bers compared. Overall, the geographical (with the 
exception of Berlin in particular) and sex distribution 
of participants were reasonably similar to that of the 
German population, but the age distribution could be 
improved. However, while other European Internet-
based monitoring systems had reported under-repre-
sentation of children [7,8,10], the two age groups of 
children in GrippeWeb (0–4 years and 5–14 years) were 
not under-represented, perhaps due to the simplicity 
and rapidity with which parents can report for their 
children. Nevertheless, similar to other Internet-based 
systems [7,8,10], the oldest age group (60 years and 
above) was under-represented in GrippeWeb, probably 
due to the lack of familiarity with the internet in this age 
group. In 2012, only 36% of persons living in Germany 
aged 65 years or older were Internet users [20]. One 
practical consequence of this under-representation is 
that other means of promoting the GrippeWeb system 
to elderly people need to be considered. The under-
representation of the 15–24 year-old age group was 
at first surprising, but might be linked to the fact that 
parents can no longer report for their children when 
they turn 14 years. In addition, health-related topics 
might be of less interest to young people in this age 
group and might result in a lower willingness to sign 
up for GrippeWeb. Furthermore, this age group might 
tend to prefer the use of smartphone apps and social 
media such as Facebook instead of ‘classic’ Internet 
Figure 4
Incidence of acute respiratory illnesses and medically attended acute respiratory illness (MAARI) measured by GrippeWeb 
and MAARI incidence measured by the German sentinel surveillance system for influenza, weeks 35/2011–34/2012
AGI: Arbeitsgemeinschaft Influenza, German sentinel surveillance system for influenza; ARI: acute respiratory illnesses; MAARI: medically 
attended acute respiratory illness.
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and email communication. Unavailability of GrippeWeb 
as a smartphone app and existing strict privacy regu-
lations (prohibiting a link with Facebook) might lower 
the attractiveness of the system to those aged 15–24 
years. 
Another way to assess representativeness is to com-
pare the proportion of participants with certain chronic 
diseases. We found a statistically significant difference 
between the proportion of GrippeWeb participants 
with asthma and diabetes compared to the proportion 
in the general population of Germany, with the partici-
pants having a lower prevalence. Data of the general 
population showed a negative association of diabe-
tes mellitus lifetime prevalence and level of education 
[15]. Hence GrippeWeb might attract individuals with 
a higher educational background, who might have a 
more health-conscious behaviour and lower rates of 
diabetes in turn.
It is very encouraging to observe the good adherence 
of GrippeWeb participants, demonstrated by the fact 
that 62% of participants reported in at least 90% of 
all possible weeks during the period under study. 
This rate is very high considering that other Internet-
based monitoring systems in Europe reported for the 
2011/12 influenza season that at most 25% of partici-
pants reported at least 90% of weeks [19]. The very 
high participation rate in GrippeWeb might be related 
to the following: (i) the personal, individualised feed-
back that is automatically given to participants in the 
form of a diary whenever they log in; (ii) the fact that 
delivering the weekly report is simple and takes only 
a few seconds when reporting no new onset of an ARI 
and up to, at most, a couple of minutes when report-
ing a respiratory illness with new onset and answering 
the related questions;  and (iii) the prize draw might 
have attracted individuals who would otherwise not 
have participated. The way prizes are drawn (increased 
chance to win with continuous participation) may have 
fostered the willingness of those eligible to report 
frequently. 
Because of the constancy of our participants, we were 
able to quantify the mean number of ARI and ILI people 
in different age groups had during one year of observa-
tion. While this number may differ to a certain extent 
from year to year, the magnitude and degree of dif-
ference between adults and children was interesting 
and declined steadily from the very young to the very 
old. Data like this are important and might be used for 
Figure 5
GrippeWeb influenza-like illness rates for children aged ≤14 years and participants aged >14 years compared with the 
number of samples positive for influenza A(H3N2) and B virusesa, Germany, weeks 35/2011–34/2012
ILI: influenza-like illness.
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calculations of burden of disease due to respiratory 
infections.
The proportion of participants sick with ARI or ILI con-
sulting a physician is also an important parameter and 
we see clear differences by severity of disease (ARI 
vs ILI) and age (children vs adults), with highest pro-
portions among 0–4 year-olds who have ILI (49%). In 
the same season, other European countries, such as 
France, Italy and Belgium, reported similar proportions 
between children and adults whereas the Netherlands 
and the United Kingdom reported rather lower pro-
portions [21]. Data on physician consultations may be 
heavily influenced by societal factors, for example, at 
which point in time employees are required to present 
a medical certificate when they become ill. 
Because the AGI system collects ARI data, we com-
pared them with GrippeWeb ARI data. The two case 
definitions are similar: while the AGI defines an ARI as 
acute onset of pharyngitis, bronchitis or pneumonia 
with or without fever, an ARI in GrippeWeb is defined 
as a subjectively reported new onset of a respiratory 
illness with fever or cough or sore throat. It was reas-
suring that the course of GrippeWeb ARI rates was sim-
ilar in its dynamic compared with the AGI MAARI rates, 
where the difference in magnitude reflects the rate at 
which patients seek professional medical advice. This 
concurs with the experience from other European sys-
tems [7-10]. The improved correlation coefficient (of 
0.80 to 0.89, when a lag of two weeks is allowed for) 
suggests that GrippeWeb ARI rates might detect sub-
stantial changes in the population perhaps one or two 
weeks earlier than the AGI system.
It is novel to compare directly and quantitatively MAARI 
rates of a sentinel-based surveillance system (that of 
AGI) with those estimated by an Internet-based moni-
toring system (GrippeWeb). It is remarkable that the 
two, entirely independent systems with different data 
sources, sampling schemes, geographical distribution 
and extrapolation procedures to the whole population 
agree not only in their weekly patterns throughout the 
year, but also estimate very similar numerical values 
(illustrated by the large correlation coefficient of 0.89). 
This agreement even holds, albeit to a lesser degree, 
after stratification into age groups (data not shown). 
We regard this as a sort of ‘mutual validation’ of the 
two systems. We were also pleased to see that the 
actual influenza circulation, as measured by the viro-
logical surveillance of the AGI,  was also reflected in 
our ILI data. However, it also shows that syndromic data 
must always be interpreted in the context of virologi-
cal surveillance. It would be even more helpful to have 
virological information (on a broader range of agents) 
from samples coming directly from participants in the 
GrippeWeb system, for example, as done in [22].
Strengths of GrippeWeb are that the system could be 
relatively easily extended or adapted according to, for 
example, acute needs in an epidemic or even pandemic 
and it could include other symptoms, such as diar-
rhoea/nausea/vomiting. Data are gathered in a timely 
manner: individual (not aggregated) data on demo-
graphic variables, lifestyle and underlying health con-
ditions of participants might allow the identification 
of risk factors to an extent that is hardly possible by 
physician-based sentinel systems. The data allow us 
to assess influenza vaccination uptake and estimate 
influenza vaccination effectiveness (to protect from 
ILI). The costs of GrippeWeb are limited when com-
pared with those of a sentinel surveillance network: 
after gathering data from further seasons, modelling 
should be capable of estimating the burden of disease 
in the population due to influenza (or other viruses, if 
data become available). 
GrippeWeb has the following limitations. Participants 
are Internet-users and may have an interest in health 
topics, which may result in a cohort with a behav-
iour that is more health conscious than that of the 
general population. We do not believe, however, that 
this specifically affects ARI and ILI rates, otherwise 
the comparison with AGI data would be substantially 
worse. The number of participants during the reported 
period was small, resulting sometimes in very small 
numbers, for example when examining age or other 
strata. Lastly self-reporting may lead to a tendency to 
report only when illness occurs. However, by including 
data of all participants only after they have reported 
four times for calculation of ARI, ILI and MAARI rates, 
we have controlled for the ‘starter bias’; moreover, 
because GrippeWeb participants reported very regu-
larly, we feel that it is justified to have a high degree 
of confidence in the data. Nevertheless, as GrippeWeb 
is a very young system, it is possible that participants’ 
motivation will decrease over time and participation 
rate will drop.
Conclusion
Already in its second year after implementation, 
GrippeWeb has become a reliable tool to estimate 
ARI and ILI in the general population. It proved to be 
a valuable complement to the physician-based senti-
nel system of the AGI. Both systems report their data 
in parallel. The constant increase of registered par-
ticipants in GrippeWeb, adequate representativeness, 
remarkably high continuity of participation and excel-
lent agreement with an independent data source (AGI) 
provide good and an increasing amount of data. The 
inclusion of an incentive system for regular participa-
tion has shown to be effective. Future strategic steps 
include a further increase of GrippeWeb subscribers 
and the collection of samples directly from GrippeWeb 
participants, for example, by using a self-swabbing 
approach.
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